Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Tandem Diabetes Care
ISIN US8753722037
|WKN A2H5BX
Market cap (in EUR)
1,101 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 1,101 m |
| EPS, EUR | -2.72 |
| P/B ratio | 8.2 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2025)
| Revenue, EUR | 899 m |
| Net income, EUR | -181 m |
| Profit margin | -20.17% |
What ETF is Tandem Diabetes Care in?
There are 37 ETFs which contain Tandem Diabetes Care. All of these ETFs are listed in the table below. The ETF with the largest weighting of Tandem Diabetes Care is the Global X Telemedicine & Digital Health UCITS ETF Dist GBP.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.